Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.

Annalisa RuggeriMyriam LabopinAndrea BacigalupoZafer GülbasYener KocDidier BlaiseBenedetto BrunoGiuseppe IrreraJohanna TischerJose Luiz Diez-MartinLuca CastagnaFabio CiceriMohamad MohtyArnon Nagler

Published in: Cancer (2018)

In patients with acute leukemia in first or second remission receiving haploidentical transplantation with PT-Cy, the use of PBSC increases the risk of acute GVHD, whereas survival outcomes are comparable. Cancer 2018;124:1428-37. © 2018 American Cancer Society.

Keyphrases

peripheral blood
bone marrow
stem cells
papillary thyroid
squamous cell
stem cell transplantation
mesenchymal stem cells
high dose
low dose
liver failure
cell therapy
squamous cell carcinoma
acute myeloid leukemia
lymph node metastasis
childhood cancer
drug induced
disease activity
ulcerative colitis